covid 19 News and Research

RSS

Colorado doubles down on abortion rights as other states — and the high court — reconsider

With the Supreme Court expected to overturn or severely weaken its landmark Roe v. Wade decision, clinics in Colorado are preparing for an increase in the number of out-of-state residents seeking abortions, and lawmakers are cementing abortion access protections in state law.

29 Mar 2022

Study tracks the rapid shift from Omicron BA.1 to BA.2 sub-variant dominance in Sweden

Researchers tracked the rapid shift from the new SARS-CoV-2 VOC Omicron BA.1 sub-variant dominance to BA.2 sub-variant dominance in Sweden between January and March 2022.

29 Mar 2022

Immune response dynamics following COVID-19 heterologous and homologous vaccinations

Researchers evaluated the cellular and humoral immunity following heterologous and homologous COVID-19 immunization regimens for up to five months.

29 Mar 2022

Newcastle disease virus-based trivalent vaccine found to be effective across SARS-CoV-2 variants in mice

In a new study, researchers tested the bi-, tri-, and tetravalent formulations of Newcastle disease virus (NDV)-based low-cost vaccine in mice.

29 Mar 2022

Association between the COVID-19 pandemic and inflammatory bowel disease presentation in New York City

Researchers evaluated the association between new IBD diagnoses in NYC and the COVID-19 pandemic.

29 Mar 2022

The relationship between circadian misalignment and the risk of COVID-19 infection

An interesting new study links changes in the daily rhythms of the human body with the risk of COVID-19.

29 Mar 2022

SCENTinel 1.1 found to rapidly screen SARS-CoV-2-linked olfactory disorders

...

29 Mar 2022

Clinical outcomes of SARS-CoV-2 coinfection with influenza viruses, respiratory syncytial virus, or adenoviruses

A recent paper examines the occurrence of other respiratory viral infections during this period in patients already infected with SARS-CoV-2.

29 Mar 2022

Results of Phase 3 Nanocovax SARS-CoV-2 vaccine trial suggest robust effectiveness

A new study presented the findings of the Phase 3 trial of the Nanocovax coronavirus disease 2019 (COVID-19) vaccine.

29 Mar 2022

Algal metabolites as novel drugs against viruses

A new review article published in the Journal of Biotechnology has provided information on various nutraceutical metabolites extracted from algae.

29 Mar 2022

Is SARS-CoV-2 a Superantigen?

Since the onset of the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), scientists have been conducting extensive studies to understand various aspects of the virus. Researchers have stated that SARS-CoV-2 manifests several biological and clinical consequences of a superantigen

29 Mar 2022

New compound delivered in a nasal spray effectively treats delta variant infection in mice

Researchers have shown a new compound delivered in a nasal spray is highly effective in preventing and treating COVID-19 caused by the Delta variant in mice.

29 Mar 2022

Is COVID-19 vaccination during pregnancy safe?

A new retrospective cohort study conducted across a large population of pregnant women in Ontario, Canada, has confirmed that the coronavirus disease 2019 (COVID-19) vaccination administered during pregnancy is not associated with any increased risk of adverse maternal or neonatal peripartum outcomes.

29 Mar 2022

Study finds low-risk of spillover SARS-CoV-2 infection from domestic cats

A recent study published in the journal One Health assessed whether the presence of a domestic cat adds to the risk of SARS-CoV-2 infection among the household members after a human index case introduces the infection.

28 Mar 2022

One year after severe COVID-19, T cells persist against SARS-CoV-2

In a recently published article in the journal eBioMedicine, scientists have demonstrated that critically ill coronavirus disease 2019 (COVID-19) patients are capable of generating durable memory T cell response against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for more than one year after hospital discharge.

28 Mar 2022

Virtual reality helps reduce COVID-19 vaccine hesitancy

A new study investigates whether intention for vaccination is increased by a gamified immersive VR experience that shows how community immunity works.

28 Mar 2022

Northwestern scientists continue to advance the understanding of COVID-19

As the COVID-19 pandemic enters its third year, Northwestern Medicine scientists continue to help advance the understanding of the disease and its impact, from investigating antibody protection against COVID-19 reinfection to elevating women in academic research and highlighting racial and ethnic disparities in COVID-19 hospital mortality in Illinois.

28 Mar 2022

covid 19 News and Research

Colorado doubles down on abortion rights as other states — and the high court — reconsider

Study tracks the rapid shift from Omicron BA.1 to BA.2 sub-variant dominance in Sweden

Immune response dynamics following COVID-19 heterologous and homologous vaccinations

Newcastle disease virus-based trivalent vaccine found to be effective across SARS-CoV-2 variants in mice

Association between the COVID-19 pandemic and inflammatory bowel disease presentation in New York City

The relationship between circadian misalignment and the risk of COVID-19 infection

SCENTinel 1.1 found to rapidly screen SARS-CoV-2-linked olfactory disorders

Clinical outcomes of SARS-CoV-2 coinfection with influenza viruses, respiratory syncytial virus, or adenoviruses

Results of Phase 3 Nanocovax SARS-CoV-2 vaccine trial suggest robust effectiveness

Algal metabolites as novel drugs against viruses

Is SARS-CoV-2 a Superantigen?

New compound delivered in a nasal spray effectively treats delta variant infection in mice

Is COVID-19 vaccination during pregnancy safe?

Study finds low-risk of spillover SARS-CoV-2 infection from domestic cats

One year after severe COVID-19, T cells persist against SARS-CoV-2

Virtual reality helps reduce COVID-19 vaccine hesitancy

Northwestern scientists continue to advance the understanding of COVID-19

Fourth COVID-19 vaccine dose substantially reduces mortality in the elderly

Natural SARS-CoV-2 antibodies persist for six months in children

Hybrid immunity and booster vaccination provides best protection against SARS-CoV-2 BA.1 and BA.2

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News